未登录

G

Gerjo J. de Knegt

Erasmus University Rotterdam

H指数:18

被引数:991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv

SCIENTIFIC REPORTS

IF3.9

2019-12-2718

OAAI

Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model

在小鼠结核病模型中评估维拉帕米对莫西沙星和利奈唑胺联合方案的附加价值

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2018-09-018

OAAI

Improving treatment outcome assessment in a mouse tuberculosis model

SCIENTIFIC REPORTS

IF3.9

2018-04-0913

OAAI

The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black Box

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY

IF0

2018-01-0645

OAAI

Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain

使用临床北京菌株评估小鼠结核病模型中的杀菌药物活性和治疗结果

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2017-10-0112

OA

Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis

在结核病小鼠模型中添加免疫疗法可减少疾病的复发

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

IF5.3

2017-02-0122

PREAI

Optimization of the Rifampin Dosage to Improve the Therapeutic Efficacy in Tuberculosis Treatment Using a Murine Model

使用小鼠模型优化利福平剂量以提高结核病治疗的疗效

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IF19.4

2013-05-1581

PREAI

A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barr, syndrome

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2012-09-04154

PREAI

Consequences of Noncompliance for Therapy Efficacy and Emergence of Resistance in Murine Tuberculosis Caused by the Beijing Genotype of Mycobacterium tuberculosis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2012-09-0125

OA

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB

EMERGING INFECTIOUS DISEASES

IF6.6

2012-04-0189

OAAI

Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

IF3.1

2011-11-0114

PREAI

Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2011-10-0912

OAAI

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2010-10-14141

OAAI

IMMUNOLOGICAL PARAMETERS TO DEFINE INFECTION PROGRESSION AND THERAPY RESPONSE IN A WELL-DEFINED TUBERCULOSIS MODEL IN MICE

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

IF2.6

2009-07-0121

PREAI